Prevalence and Determinants of Polypharmacy: A Cross‐Sectional Study Among Elderly Patients With Cardiovascular Diseases in Outpatient Clinics
Negin Faramarzi Nasab, Shahab Rezaeian, Saeed Ezadi, Alireza Khatony · 2025
Read Prevalence and Determinants of Polypharmacy: A Cross‐Sectional Study Among Elderly Patients With Cardiovascular Diseases in Outpatient Clinics by Negin Faramarzi Nasab, Shahab Rezaeian, Saeed Ezadi, Alireza Khatony (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12782334.txt.
Description
Negin Faramarzi Nasab and co-authors measure how common heavy medication use is among older heart patients in Iran. Their 2025 study defines polypharmacy as five or more drugs at once. Such use raises risks of drug interactions, errors, and hospital stays. Evidence from poorer countries is limited, the authors note. The survey covered 426 outpatients in Kermanshah, chosen by convenience sampling. Data came from structured questionnaires.
About sixty percent, 60.1 percent, took five to nine drugs daily. Heavy use linked to lower education and income. Longer treatment, past hospital stays, and many chronic conditions also raised it. So did weak pharmacist counseling and poor knowledge of one's drugs. In the full model, three factors stood out as independent predictors. Many chronic conditions, hospital history, and poor drug knowledge each raised the odds about five to six fold. The authors call for targeted support for these patients.
Catalog record
| CREATOR | Negin Faramarzi Nasab, Shahab Rezaeian, Saeed Ezadi, Alireza Khatony |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |